REGISTER
MedJ at JSCO 2025 with Dr. Takayuki Yoshino
MedJ at JSCO 2025 with Dr. Takayuki Yoshino is presented here as a key issue in JSCO. The summary connects evidence on JSCO, MD, medj with who may benefit, what risks matter most, and how practice could change.

Takayuki Yoshino, MD, National Cancer Center Hospital East, Japan

As President of JSCO, he looks forward to collaborating with Chinese oncology experts and associations to foster closer academic exchanges and jointly advance the standards of cancer care across Asia!

0
0
Loading